Chantix can help even light smokers quit, study says

[Nicotine and Tobacco Research, Sept. 2016] Though the overall prevalence of cigarette smoking has declined, the proportion of smokers who smoke less than 10 cigarettes/day has increased. This study was a 12-week, randomized, placebo-controlled clinical trial looking at the use of Chantix in this population.

At end-of-treatment (3 months),  the prolonged smoking abstinence rate was 40.0% in the Chantix group and 8.3% in the placebo group. At end-of-study (6 months), the prolonged smoking abstinence rate was 31.1% and 8.3%, respectively, suggesting that Chantix might be a good option even for light smokers who are looking to quit smoking.

Click here to read the full article.